Ignite Creation Date:
2024-10-25 @ 8:00 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06531993
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-06-10
Brief Title:
Effect of Pectin in Chronic Kidney Disease Patients Stage 3 and 4
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effect of Pectin in Chronic Kidney Disease Patients Stage 3 and 4
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Effect of pectin in chronic kidney disease patients
Detailed Description:
Chronic kidney disease CKD is a serious global health problem leading to serious comorbidities end-stage renal disease ESRD and death
From 1990 to 2016 the prevalence of CKD increased by 90 worldwide which is closely tied to the increase in at-risk populations with diabetes mellitus DM hypertension HTN and prediabetes It is estimated to be around 91 to 134 This means there are about 700 million to over 800 million cases of CKD worldwide
In 2017 CKD resulted in 12 million deaths and was the 12th leading cause of death worldwide And in the same year the estimated prevalence of CKD in Egypt was 71 million individuals which means 106 patients1000 population
Pectin a class of heteropolysaccharides based on polygalacturonic acid is a safe and non-toxic natural food additive recommended by the Joint FAOWHO Committee on Food Additives with no daily additive limit Pectin is mainly obtained from apple pomace citrus peels and sugar beets ancurrently commercial pectin contains 65 Gal-A galacturonic acid
Among the patients who tried to take the pectin unexpectedly was found that the pectin had a significant effect on the rapid reduction of blood creatinine concentration in patients with chronic kidney disease So the authors followed up the physical examination indeces of chronic kidney disease patients who took the Pectin
From 1990 to 2016 the prevalence of CKD increased by 90 worldwide which is closely tied to the increase in at-risk populations with diabetes mellitus DM hypertension HTN and prediabetes It is estimated to be around 91 to 134 This means there are about 700 million to over 800 million cases of CKD worldwide
In 2017 CKD resulted in 12 million deaths and was the 12th leading cause of death worldwide And in the same year the estimated prevalence of CKD in Egypt was 71 million individuals which means 106 patients1000 population
Pectin a class of heteropolysaccharides based on polygalacturonic acid is a safe and non-toxic natural food additive recommended by the Joint FAOWHO Committee on Food Additives with no daily additive limit Pectin is mainly obtained from apple pomace citrus peels and sugar beets ancurrently commercial pectin contains 65 Gal-A galacturonic acid
Among the patients who tried to take the pectin unexpectedly was found that the pectin had a significant effect on the rapid reduction of blood creatinine concentration in patients with chronic kidney disease So the authors followed up the physical examination indeces of chronic kidney disease patients who took the Pectin
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None